Renal angiomyolipoma (AML) is associated with complex clinical situations s
uch as tumour in a solitary kidney, bilateral, large or multicentric tumour
s or those associated with tuberous sclerosis (TS) or pregnancy. Management
in these situations may be challenging. Fifteen patients (20 kidneys) were
admitted with symptomatic AML over last 10 years. Eleven patients had one
or the other complicating factor. Ten patients had a tumour of > 10 cm, 4 h
ad TS, 5 had multiple and bilateral tumours, 1 patient was pregnant and 1 h
ad a solitary functioning kidney. With the newer imaging modalities correct
diagnosis was possible in 12 cases and renal cell carcinoma (RCC) was susp
ected in 3 cases. Selective angioembolization (SAE) was done in 3 patients,
which successfully controlled bleeding in all. Nephron-sparing surgery (NS
S) was performed in 5 patients. Total nephrectomy was done in 4 cases, in 3
due to suspicion of RCC and in 1 due to extensive involvement of the kidne
y. Three patients with multiple and bilateral tumours were chosen for conse
rvative treatment and none developed recurrence of bleeding on strict follo
w-up. In a pregnant patient, bleeding was successfully controlled with angi
oembolization. However, 1 patient with a solitary functioning kidney with l
arge-sized tumour (20 x 18 cm) underwent NSS. In conclusion, the basis of m
anagement of AML is preservation of renal tissue, which can be effectively
achieved with SAE or NSS. In a solitary functioning kidney, NSS or SAE is t
he ideal treatment, if feasible. The patients in the TS group are usually m
ore complicated and require life-long follow-up after initial management wi
th NSS or SAE. Pregnant AML patients can be safely managed with SAE. Conser
vative treatment without any intervention and regular follow-up may be more
helpful in some patients with multiple, bilateral extensive tumours. Copyr
ight (C) 2001 S. Karger AG, Basel.